teresa giraldez
University of La Laguna
San Cristóbal de La Laguna, Spain
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of La Laguna
San Cristóbal de La Laguna, Spain
Review Editor
Pharmacology of Ion Channels and Channelopathies
The University of Texas at Austin
Austin, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Spanish National Research Council (CSIC)
Madrid, Spain
Review Editor
Pharmacology of Ion Channels and Channelopathies
Newcastle University
Newcastle upon Tyne, United Kingdom
Review Editor
Pharmacology of Ion Channels and Channelopathies
School of Medicine, Yale University
New Haven, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Queensland University of Technology
Brisbane, Australia
Review Editor
Pharmacology of Ion Channels and Channelopathies
Idaho State University
Pocatello, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Flinders University
Adelaide, Australia
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of Copenhagen
Copenhagen, Denmark
Review Editor
Pharmacology of Ion Channels and Channelopathies
Ludwig Maximilian University of Munich
Munich, Germany
Review Editor
Pharmacology of Ion Channels and Channelopathies
National Council of Humanities, Sciences and Technologies (CONAHCYT)
Ciudad de México, Mexico
Review Editor
Pharmacology of Ion Channels and Channelopathies
Pfizer
New York, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Brandeis University
Waltham, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of Vermont
Burlington, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
The Neurosensory Research Center, University of Oldenburg
Oldenburg, Germany
Review Editor
Pharmacology of Ion Channels and Channelopathies
Emory University
Atlanta, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies